[{"Assets_0_Q1_USD":247068000.0,"CommonStockSharesOutstanding_0_Q1_shares":564859960.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-47279000.0,"NetIncomeLoss_1_Q1_USD":-21078000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":8196000.0,"Ticker":"ADAP","CIK":"1621227","name":"ADAPTIMMUNE THERAPEUTICS PLC","OfficialName":"Adaptimmune Therapeutics plc American Depositary Shares","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301181409.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]